The Release of Inflammatory Mediators from Acid-Stimulated Mesenchymal Stromal Cells Favours Tumour Invasiveness and Metastasis in Osteosarcoma.

acid microenvironment inflammatory cytokines mesenchymal stromal cells metastasis osteosarcoma

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
22 Nov 2021
Historique:
received: 18 10 2021
revised: 10 11 2021
accepted: 17 11 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 28 11 2021
Statut: epublish

Résumé

Osteosarcoma is the most frequent primary malignant bone tumour with an impressive tendency to metastasise. Highly proliferative tumour cells release a remarkable amount of protons into the extracellular space that activates the NF-kB inflammatory pathway in adjacent stromal cells. In this study, we further validated the correlation between tumour glycolysis/acidosis and its role in metastases. In patients, at diagnosis, we found high circulating levels of inflammatory mediators (IL6, IL8 and miR-136-5p-containing extracellular vesicles). IL6 serum levels significantly correlated with disease-free survival and

Identifiants

pubmed: 34831016
pii: cancers13225855
doi: 10.3390/cancers13225855
pmc: PMC8616358
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Italian Association for Cancer Research
ID : 20153
Organisme : Italian Association for Cancer Research
ID : 21403

Références

Oncotarget. 2014 Sep 15;5(17):7575-88
pubmed: 25277190
Int J Oncol. 2013 Jul;43(1):95-102
pubmed: 23636271
Mol Med Rep. 2017 Nov;16(5):7423-7431
pubmed: 28944885
Oncotarget. 2016 Sep 27;7(39):63408-63423
pubmed: 27566564
J Cell Biochem. 2020 Jul;121(7):3479-3490
pubmed: 31898371
Semin Cancer Biol. 2017 Apr;43:119-133
pubmed: 28188829
J Cell Physiol. 2020 May;235(5):4734-4745
pubmed: 31637737
Cancer Treat Rev. 2006 Oct;32(6):423-36
pubmed: 16860938
Cancers (Basel). 2021 Jan 15;13(2):
pubmed: 33467731
Exp Cell Res. 2014 Jan 1;320(1):21-32
pubmed: 24416789
Arthritis Rheum. 1966 Feb;9(1):47-56
pubmed: 4952418
Cancers (Basel). 2021 Jul 30;13(15):
pubmed: 34359749
PLoS One. 2019 Nov 25;14(11):e0225242
pubmed: 31765423
Cancer Lett. 2017 Oct 1;405:90-99
pubmed: 28774797
Cold Spring Harb Perspect Biol. 2009 Nov;1(5):a000141
pubmed: 20066113
PLoS One. 2014 Oct 20;9(10):e110340
pubmed: 25329465
Genome Biol. 2009;10(6):R64
pubmed: 19531210
Magn Reson Med. 2011 Jan;65(1):202-11
pubmed: 20949634
PLoS One. 2010 Jun 08;5(6):e10999
pubmed: 20544017
EMBO Mol Med. 2020 Nov 6;12(11):e11131
pubmed: 33047515
Nat Rev Cancer. 2017 Oct;17(10):577-593
pubmed: 28912578
Cancers (Basel). 2020 Jul 29;12(8):
pubmed: 32751163
Tumour Biol. 2014 Feb;35(2):1023-8
pubmed: 23999825
N Engl J Med. 1986 Dec 25;315(26):1650-9
pubmed: 3537791
Biochim Biophys Acta. 2016 Jan;1862(1):72-81
pubmed: 26499398
Cancer Lett. 2009 Aug 18;281(1):32-41
pubmed: 19342158
Clin Exp Metastasis. 2021 May 17;:
pubmed: 33999364
Oncogene. 2021 Jul;40(26):4440-4452
pubmed: 34108617
Pathogens. 2015 Nov 27;4(4):826-68
pubmed: 26633519
Biochim Biophys Acta. 2013 Aug;1832(8):1105-16
pubmed: 23579072
Calcif Tissue Int. 2018 Feb;102(2):174-195
pubmed: 29238848
Cell Physiol Biochem. 2018;50(2):512-524
pubmed: 30308489
Int J Mol Sci. 2018 Sep 26;19(10):
pubmed: 30261649
Cancer Res. 2010 May 1;70(9):3718-29
pubmed: 20388793
J Surg Oncol. 2003 Nov;84(3):151-9
pubmed: 14598359
Int J Cancer. 2017 Mar 15;140(6):1331-1345
pubmed: 27888521
Int Orthop. 2021 May;45(5):1337-1346
pubmed: 33392682
PLoS One. 2013 Nov 04;8(11):e78505
pubmed: 24223816
Biochim Biophys Acta. 2013 Dec;1836(2):321-35
pubmed: 24183942
Cell Physiol Biochem. 2017;44(3):1224-1241
pubmed: 29179211
Int J Oncol. 2008 Dec;33(6):1231-8
pubmed: 19020756
Immunol Rev. 2015 Mar;264(1):182-203
pubmed: 25703560
J Thorac Oncol. 2011 Jan;6(1):209-17
pubmed: 21107292
Cancer Res. 2016 Nov 15;76(22):6463-6470
pubmed: 27651313
Adv Exp Med Biol. 2020;1234:15-29
pubmed: 32040852
Biomed Res Int. 2019 Jul 8;2019:8275935
pubmed: 31360726
Cancers (Basel). 2019 Jan 24;11(2):
pubmed: 30682793
Nat Rev Immunol. 2018 May;18(5):309-324
pubmed: 29379212
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Hum Gene Ther. 1999 May 1;10(7):1163-73
pubmed: 10340548
Stem Cell Rev Rep. 2021 Apr 26;:
pubmed: 33904115
Cancer Lett. 2012 Dec 1;325(1):80-8
pubmed: 22743617
Adv Exp Med Biol. 2020;1234:31-42
pubmed: 32040853
Oncogene. 2018 May;37(22):2903-2920
pubmed: 29515232
Arthritis Res Ther. 2020 Oct 27;22(1):256
pubmed: 33109253
Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2715-26
pubmed: 25449995
Clin Cancer Res. 2017 Jul 15;23(14):3721-3733
pubmed: 28053020
Oncotarget. 2017 Apr 13;8(33):54478-54496
pubmed: 28903357
Int J Hyperthermia. 1995 Mar-Apr;11(2):211-6
pubmed: 7790735
Int J Oncol. 2017 Aug;51(2):498-506
pubmed: 28714513
Nature. 2006 May 25;441(7092):437-43
pubmed: 16724055

Auteurs

Sofia Avnet (S)

Department of Biomedical and Neuromotor Sciences, University of Bologna, 40127 Bologna, Italy.

Silvia Lemma (S)

Department of Biomedical and Neuromotor Sciences, University of Bologna, 40127 Bologna, Italy.

Margherita Cortini (M)

BST Biomedical Science and Technologies Lab, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Gemma Di Pompo (G)

BST Biomedical Science and Technologies Lab, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Francesca Perut (F)

BST Biomedical Science and Technologies Lab, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Maria Veronica Lipreri (MV)

Department of Biomedical and Neuromotor Sciences, University of Bologna, 40127 Bologna, Italy.

Laura Roncuzzi (L)

BST Biomedical Science and Technologies Lab, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Marta Columbaro (M)

BST Biomedical Science and Technologies Lab, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Costantino Errani (C)

Oncologic Orthopaedic Unit, IRCCS Istituto Ortopedico Rizzoli, 40126 Bologna, Italy.

Alessandra Longhi (A)

Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Nicoletta Zini (N)

CNR Institute of Molecular Genetics "Luigi Luca Cavalli-Sforza", Unit of Bologna, via di Barbiano 1/10, 40136 Bologna, Italy.
IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Dominique Heymann (D)

Institut de Cancérologie de l'Ouest, Tumor Heterogeneity and Precision Medicine, Université de Nantes, 44805 Saint-Herblain, France.

Massimo Dominici (M)

Division of Oncology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy.

Giulia Grisendi (G)

Division of Oncology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy.

Giulia Golinelli (G)

Division of Oncology, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy.

Lorena Consolino (L)

Department of Molecular Biotechnology and Health Sciences, University of Turin, 10126 Torino, Italy.

Dario Livio Longo (DL)

Institute of Biostructures and Bioimaging (IBB), Italian National Research Council (CNR), 10125 Torino, Italy.

Cristina Nanni (C)

Nuclear Medicine Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

Alberto Righi (A)

Surgical Pathology Unit, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Nicola Baldini (N)

Department of Biomedical and Neuromotor Sciences, University of Bologna, 40127 Bologna, Italy.
BST Biomedical Science and Technologies Lab, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.

Classifications MeSH